APA

Hinterberger-Fischer M., Ogris E., Kier P., Bauer K., Kittl E., Habertheuer K. H., Ruckser R., Schmid A., Selleny S., Fangl M., Sebesta C. & Hinterberger W. (20000921). Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?. : American journal of clinical oncology.

Chicago

Hinterberger-Fischer M, Ogris E, Kier P, Bauer K, Kittl E, Habertheuer K H, Ruckser R, Schmid A, Selleny S, Fangl M, Sebesta C and Hinterberger W. 20000921. Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?. : American journal of clinical oncology.

Harvard

Hinterberger-Fischer M., Ogris E., Kier P., Bauer K., Kittl E., Habertheuer K. H., Ruckser R., Schmid A., Selleny S., Fangl M., Sebesta C. and Hinterberger W. (20000921). Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?. : American journal of clinical oncology.

MLA

Hinterberger-Fischer M, Ogris E, Kier P, Bauer K, Kittl E, Habertheuer K H, Ruckser R, Schmid A, Selleny S, Fangl M, Sebesta C and Hinterberger W. Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?. : American journal of clinical oncology. 20000921.